Children with sickle cell disease and the Duffy null phenotype may have lower measured neutrophil counts, but new research suggests that there are opportunities to optimize hydroxyurea regardless of Duffy null status. Sickle cell disease (SCD) primarily affects individuals of minority populations and can cause numerous morbidities, including vaso-occlusive pain, acute chest syndrome episodes, and […]| Pediatrics Nationwide
A new cellular therapy approach could improve outcomes and ease the treatment burden for patients and families.| Pediatrics Nationwide
A subset of patients with high-risk neuroblastoma (NBL) and primary adrenal tumors develop an adrenal insufficiency (AI)-like phenotype during treatment.| Pediatrics Nationwide
Nationwide Children’s researchers develop a scalable, targeted approach to overcoming cancer’s toughest challenges.| Pediatrics Nationwide
A new umbrella trial of molecularly driven therapies for high-grade gliomas (HGG) and diffuse intrinsic pontine glioma (DIPG) aims to improve quality of live and extend survival rates for these aggressive tumors.| Pediatrics Nationwide
For people with sickle cell disease who menstruate, hormonal contraception can be effective against SCD-related pain, but it also raises the risk of thrombosis. | Pediatrics Nationwide
Recent research shows that a commonly inherited polymorphism could impact outcomes.| Pediatrics Nationwide